Dtsch Med Wochenschr 2006; 131(28/29): 1615
DOI: 10.1055/s-2006-947808
Pro & Contra | Commentary
Dermatologie
© Georg Thieme Verlag KG Stuttgart · New York

Topische Calcineurin-Inhibitoren bei atopischem Ekzem - Contra

Topical calcineurin inhibitors in atopic eczema - contraD. Abeck1
  • 1Hautzentrum Harlaching, München
Further Information

Publication History

eingereicht: 13.3.2006

akzeptiert: 16.3.2006

Publication Date:
06 July 2006 (online)

Literatur

  • 1 Anonymous . Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough.  Prescrire Int. 2004;  13 209-212
  • 2 Becker J C, Houben R, Vetter C S, Bröker C S. The carcinogenic potential of tacrolimus beyond immune suppression: a hypothesis creating case report.  BMC Cancer. 2006;  6 7
  • 3 Garside R, Stein K, Castelnuovo E. et al . The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.  Health Technol Assess. 2005;  9 1-230
  • 4 Niedner R. Kortikoide in der Dermatologie.  UniMed, Bremen. 1998;  63-64
  • 5 Paller A S, Lebwohl M, Fleicher A B. et al . Tacrolimus ointment is more effective than pimecrolimus cream with a similar saftey profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies.  J Am Acad Dermatol. 2005;  52 810-822

Prof. Dr. med. Dietrich Abeck

Hautzentrum Harlaching

Grünwalder Straße 248

81545 München

Email: Dietrich.Abeck@lrz.tu-muenchen.de

    >